Treatment of Persistent Chemotherapy-Induced Hair Loss (Alopecia) With Human Mesenchymal Stromal Cells Exosome Enriched Extracellular Vesicles: A Case Report

    April 2023 in “ Heliyon
    Amir Hossein Norooznezhad, Reza Yarani, Mehrdad Payandeh, Zohreh Hoseinkhani, Hamidreza Mahmoudi, Sarah Kiani, Kamran Mansouri
    Image of study
    TLDR A woman regrew her hair after receiving injections of special cell-derived vesicles.
    This case report details the successful treatment of a 36-year-old woman with persistent chemotherapy-induced alopecia (PCIA) using extracellular vesicles (EVs) derived from human placental mesenchymal stromal cells (MSCs). The patient, who had undergone chemotherapy for invasive ductal carcinoma, experienced no significant hair regrowth for 18 months post-treatment. She received subcutaneous injections of MSC-derived EVs every 4 weeks for 3 months, resulting in complete regrowth of terminal hair on her scalp. The study suggests that MSC-derived EVs could be a potential treatment for PCIA, though further research with a larger patient cohort is necessary to confirm these findings.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 42 results

      community Hair greed made me switch to Dut too early

      in Chat  42 upvotes 3 weeks ago
      The user switched from finasteride to dutasteride for hair loss but faced increased shedding and anxiety, regretting not staying with finasteride longer. Other users shared mixed experiences, advising patience with dutasteride, as it may take up to a year to show results.

    Similar Research

    5 / 1000+ results